Voxilaprevir

Synonym
Product Category
Product Code
CAS Number
MDL Number
Pubchem CID
Reaxys RN
GS9857
API & Intermediates
KAPI4F01
1535212-07-7

89921642
26517059
image-155171-Trimethyl(trifluoromethyl)silane_reagent.png
Chemical Name
Molecular Formula
Molecular Weight
Assay
Appearance
Melting Point
Packaging
Storage
Voxilaprevir
C40H52F4N6O9S
868.95
≥99%(HPLC)
Off-white to White Solid

500mg,1g,5g,10g,25g,50g and 100g
-20°C Freezer
Voxilaprevir (also known as GS9857) is a hepatitis C virus (HCV) nonstructural (NS) protein 3/4A protease inhibitor that is used in combination with sofosbuvir and velpatasvir for treatment of HCV infection.
Efficacy of Sofosbuvir, Velpatasvir, and GS-9857 in Patients With Hepatitis C Virus Genotype 2, 3, 4, or 6 Infections in an Open-Label, Phase 2 Trial. [1]
Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection. [2]
Establishment of robust HCV genotype 4d, 5a, and 6a replicon systems. [3]
References:
[1] E.J.Gane, et al, Gastroenterology, 2016, 151(5), pp 902-909.
[2] M.Bourliere, et al, N. Engl. J. Med., 2017, 376(22), pp 2134-2146.
[3] G.Camus, et al, Virology, 2018, 514, pp 134-141.
Signal Word
Hazard Statements
Precautionary Statements
HS Code
RIDADR
Legal Information
Not classified as a dangerous goods



NONH for all modes of transport
Sales restrictions may apply.
1. Product Specification
Available on request.
2. Safety Data Sheet
Available on request.
Please inquire for pricing and availability of this product by writing email to sales@kumidas.com.